What Veracyte changed

• Added new top-level navigation links for Resources, Innovation, Company, and Investors.
• Added specific labels for "Healthcare Providers" and "Patients and Caregivers" in the support section.
• Reorganized the "Innovation" menu by removing the TrueMRD Platform link from the primary technology list.
• Updated the impact statistics section, changing ">900 K" patients to ">0 K," ">600" publications to ">0," and ">35" trials to ">0."
• Simplified the "Financials" and "Governance" sub-menus in the Investor section.

The company has reorganized its website navigation to make it easier for providers and patients to find specific resources. However, several key performance metrics (patient counts, publications, and trials) currently show as zero, which may be a temporary data error during their site update.

• Updated the number of patients benefited from "0 K" to ">900 K."
• Updated the number of peer-reviewed publications from "0" to ">600."
• Updated the number of Phase 2 & 3 trials from "0" to ">35."
• Added the TrueMRD Platform to the Innovation navigation menu.
• Updated the NCCN Guidelines reference for the Decipher Prostate test to version 7.2026.
• Reorganized the mobile navigation menu to include direct links for Resources, Innovation, Company, and Investors.

The company updated its core proof points, showing a significant increase in peer-reviewed publications and clinical trials. This strengthens their competitive position by providing more scientific validation for their cancer tests to doctors and insurance payers.

• The mobile navigation menu was updated to include direct links for Resources, Innovation, Company, and Investors.
• New section headers were added to the homepage to help "Healthcare Providers" and "Patients and Caregivers" find relevant information.
• Several links in the "Innovation" and "Financials" sections were reorganized or simplified.
• Some statistics in the "Market-leading cancer tests" section appear to have reset to zero, which is likely a temporary technical error.

The website now has a cleaner navigation menu and clearer labels for different groups of people. This makes it easier for doctors and patients to find specific cancer tests and resources quickly.